ProPhase Labs Unveils Project ZenQ-AI
Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development. Garden City,...
Healthcare
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that...
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Dr. Khan, formerly the Chief Data Science Officer and Global Head of Strategy and Portfolio, Innovative Medicine R&D at Johnson...
New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion
Data Presented at the American College of Cardiology Scientific Sessions; Research Letter Published in the Prestigious American Heart Journal Oak...
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
Names Ed Pershing as Chief Executive Officer and Dominic Rodrigues as President KNOXVILLE, TN, April 16, 2024 (GLOBE NEWSWIRE) --...
GeneType Clinicians’ Adoption Growing – Sales up 5-Fold Year on Year
MELBOURNE, Australia, April 16, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader...
FountainRx Selects Inovalon’s ScriptMed® Software To Enhance Patient Care and Scale Specialty and Infusion Pharmacy Services
ScriptMed Cloud-Based SaaS Software Enables Data-Driven Workflows and Provides More Personalized, Cost-Effective Care for Patients with Complex Health ConditionsBOWIE, Md.,...
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated...
Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform
VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30)...
Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
- Appointment Adds Broad Expertise in Business Strategy, Collaborations, Finance, and M&A with Recent Ophthalmic Experience - Tony Gibney Tony...
Treace Announces First Annual National Bunion Day
Focus on Foot Health Issue Affecting Millions of People Includes Outreach and Education Efforts to Build Awareness, Reduce Stigma and...
Multicancer Screening Market Projected to Reach $2.72 billion by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 15, 2024 /PRNewswire/ -- The report titled "Multicancer Screening Market by Product (AI and Machine Learning-Based Platforms,...
LevelJump Announces That It Will Be Delayed in Filing Year-End Reporting Documents
Toronto, Ontario--(Newsfile Corp. - April 15, 2024) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") announces today that...
New Legislation Promotes Diversity in Allied Health Professions, Including AARC Respiratory Therapists
IRVING, TX / ACCESSWIRE / April 15, 2024 / A bill introduced on Monday, April 15, will pave the way...
Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS #AAPI--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and...
Convatec launches new Esteem Body™ with Leak Defense™
Latest ostomy system advancement in soft convexity BRIDGEWATER, N.J., April 15, 2024 /PRNewswire/ -- Convatec, a leading global medical products...
Adastra Holdings Announces Lachlan McLeod as Interim CEO
LANGLEY, BC / ACCESSWIRE / April 15, 2024/ Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis processor...
Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®, its Third Approved Biosimilar in the U.S.
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius SE, with an intravenous and subcutaneous...
Netsmart Launches the Netsmart Marketplace Advancing Interoperability and Integration Offerings for Community-Based Care Providers
OVERLAND PARK, Kan.--(BUSINESS WIRE)--#EHR--Netsmart, an industry-leading provider of healthcare technology solutions and services for community-based providers, unveils the Netsmart Marketplace....
Banner Health Enhances Surgical Efficiencies with the Qventus Perioperative Solution
Non-Profit Health System Elevates AI Strategy to Enhance Patient and Staff Experiences by Optimizing OR TimeSAN FRANCISCO--(BUSINESS WIRE)--Qventus, Inc. announced...